A citretin plus UV-B phototherapy is a highly effective and relatively safe treatment for psoriasis, limited by the inconvenience and cost of office-based treatment.
Results. Twenty-two of 27 participants completed the 12-week study (Figure) . The regimen was well tolerated. A few subjects experienced mild alopecia and increased photosensitivity. Elevation of triglyceride levels was noted in several subjects and led to decreased acitretin dose (to 10 mg/d) in 4 subjects.
Mean baseline PASI was 18.6 and decreased to 13.9 by week 12, a mean improvement of 22% (P=.004). Only 4 subjects achieved a PASI of 50, and none reached a PASI of 75 by week 12. Mean DLQI scores improved over the 12 weeks from 11.9 to 7.0 (P Յ.001). The improvements in the DLQI were of sufficient magnitude to improve subjects' quality of life. 3 The question 10 score on the DLQI decreased from 1.37 at baseline to 0.89 at week 12 (P=.04), indicating a high level of satisfaction with the study treatment.
Comment. Low-dose acitretin increases the potency of phototherapy while reducing the amount of phototherapy required for clearing and the potential for acitretin adverse effects. 4, 5 The combination of officebased narrowband UV-B therapy plus low-dose acitretin is very effective, but it is inconvenient for many pa- tients. Home-based phototherapy may reduce inconvenience and cost, but there is little information on the safety or efficacy of this approach. While there was not a high level of improvement in PASI scores in this study, subjects tolerated the treatment well and were generally satisfied with the treatment. This study used home-based narrowband UV-B light units fitted with an electronic control that provides a set number of treatments. When these treatments have been used, patients must contact their physician for a new code to get additional treatments. This provides an additional safety measure to prevent long-term use without supervision.
Limitations of this study include small study population, a relatively short duration of therapy, and a conservative escalation of light dose. The lack of burning and modest efficacy may reflect that the subjects received approximately one-quarter of the recommended UV dose (standing 12 in from the light unit vs 6 in). However, we did not reach a plateau in PASI by week 12, so ultimate efficacy levels might be higher. Perhaps a more aggressive UV exposure, such as standing closer to the unit or longer exposure times, would have been more effective at clearing lesions.
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Patient-Centered Care in Dermatology:
An Online System That Provides Accessible and Appropriate Information to Guide Patients' Decision Making H ealth care is traditionally structured around the conventional office consultation. Complaints about this system include insufficient counseling on management options and insufficient attention to patient concerns and beliefs. 1 In addition, patients frequently cannot remember the basic structure of their care plan.
2 A patient-centered access model has been suggested to improve availability, appropriateness, preference, and timeliness. 3 The University Hospital Zürich in Switzerland has offered an Internet-based question-answering service to the general public free of charge since 1999 (https://www2 .onlineberatung.usz.ch/question/faq.aspx?qst_cat _id=17). While most inquiries are answered by a general practitioner, some are referred to specialists, dermatologists being the most requested specialists, which suggests that our specialty is in generally high demand.
Methods. From 2000 to 2005, 16 106 questions were submitted to the University Hospital Zürich Internet-based question-answering service. Of these, 937 questions from 648 online questioners (hereinafter called contacts) concerned dermatology (5.8%). A Web link to an Internetbased questionnaire was e-mailed to these dermatology contacts. Institutional review board approval was obtained for the study.
